Is the personality characteristic "impulsive sensation seeking" correlated to differences in current smoking between ulcerative colitis and Crohn's disease patients?

General Hospital Psychiatry

Volumn 32, Issue 1, 2010, Pages 57-65

  Hyphantis, Thomas ^a,b   Antoniou, Katerina ^a   Tomenson, Barbara ^b   Tsianos, Epameinondas ^a   Mavreas, Venetsanos ^a   Creed, Francis ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Individual differences; Inflammatory bowel disease; Personality; Psychological distress; Smoking

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISTRESS SYNDROME; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PERSONALITY TEST; PROGNOSIS; SMOKING; TOBACCO DEPENDENCE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; EXPLORATORY BEHAVIOR; FEMALE; GREECE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PERSONALITY; QUESTIONNAIRES; RISK FACTORS; SMOKING; STRESS, PSYCHOLOGICAL; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 73549111773     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2009.09.002     Document Type: Article

References (61)

1. Birrenbach T., and Böcker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10 6 (2004) 848-859
2. Lakatos P.L., Szamosi T., and Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly?. World J Gastroenterol 13 46 (2007) 6134-6139
3. Brignola C., Belloli C., Ardizzone S., et al. The relationship between heritability and smoking habits in Crohn's disease: Italian Cooperative Study Group. Am J Gastroenterol 95 (2000) 3171-3175
4. Bridger S., Lee J.C., Bjarnason I., et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 51 (2002) 21-25
5. Sternberg E.M., Chrousos G.P., Wilder R.L., et al. The stress response and the regulation of inflammatory disease. Ann Intern Med 117 (1992) 854-866
6. Sternberg E.M. Neuroendocrine factors in susceptibility to inflammatory disease: focus on the hypothalamic-pituitary-adrenal axis. Horm Res 43 (1995) 159-161
7. Munafò M.R., Zetteler J.I., and Clark T.G. Personality and smoking status: a meta-analysis. Nicotine Tob Res 9 3 (2007) 405-413
8. Zuckerman M., and Neeb M. Demographic influences in sensation seeking and expressions of sensation seeking in religion, smoking, and driving habits. Pers Individ Dif 1 (1980) 197-206
9. Goldring J.F., Harper G.T., and Brent-Smith H. Personality, drinking and drug-taking correlates of cigarette smoking. Pers Individ Dif 4 (1983) 703-706
10. Zuckerman M., Ball S., and Black J. Influences of sensation seeking, gender, risk appraisal, and situational motivation on smoking. Addict Behav 15 3 (1990) 209-220
11. Barrett S.M., Standen P.J., Lee A.S., et al. Personality, smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 8 7 (1996) 651-655
12. Zuckerman M. Sensation seeking: beyond the optimal level of arousal (1979), Erlbaum, Hillsdale (NJ)
13. Zuckerman M. Behavioral expressions and biosocial bases of sensation seeking (1994), Cambridge University Press, New York
14. Zuckerman M., and Kuhlman D.M. Personality and risk-taking: common biosocial factors. J Pers 68 6 (2000) 999-1029
15. Zuckerman M., Kuhlman D.M., Teta P., et al. A comparison of three structural models of personality: the big three, the big five, and the alternative five. J Pers Soc Psychol 65 (1993) 757-768
16. Zuckerman M. Impulsive unsocialized sensation seeking: the biological foundations of a basic dimension of personality. In: Bates J.E., and Wachs T.D. (Eds). Temperament: individual differences at the interface of biology and behaviour (1994), American Psychological Association, Washington, DC 219-255
17. Zuckerman M. Zuckerman-Kuhlman Personality Questionnaire (ZKPQ): an alternative five-factorial model. In: de Raad B., and Perugini M. (Eds). Big five assessment (2002), Hogrefe & Huber, Gottingen, Germany 377-396
18. Mitchell S.H. Measuring impulsivity and modeling its association with cigarette smoking. Behav Cogn Neurosci Rev 3 4 (2004) 261-275
19. Reuter M., and Netter P. The influence of personality on nicotine craving: a hierarchical multivariate statistical prediction model. Neuropsychobiology 44 1 (2001) 47-53
20. Reuter M., Netter P., Rogausch A., et al. The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects. Hum Psychopharmacol 17 5 (2002) 213-224
21. Benowitz N.L. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med 121 4 Suppl 1 (2008) S3-S10
22. Nides M. Update on pharmacologic options for smoking cessation treatment. Am J Med 121 4 Suppl 1 (2008) S20-S31
23. Le Foll B., Forget B., Aubin H.J., et al. Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addict Biol 13 2 (2008) 239-252
24. Garwood C.L., and Potts L.A. Emerging pharmacotherapies for smoking cessation. Am J Health Syst Pharm 64 16 (2007) 1693-1698
25. Goldberg D.P., and Hillier V.F. A scaled version of the General Health Questionnaire. Psychol Med 9 (1979) 139-145
26. Morris P.L., and Goldberg R.J. Validity of the 28-item General Health Questionnaire in hospitalized gastroenterology patients. Psychosomatics 30 3 (1989) 290-295
27. Garyfallos G., Karastergiou A., Adamopoulou A., et al. Greek version of the General Health Questionnaire: accuracy of translation and validity. Acta Psychiatr Scand 84 (1991) 371-378
28. Rossier J., Aluja A., Garcia L.F., et al. The cross-cultural generalizability of Zuckerman's alternative five-factor model of personality. J Pers Assess 89 2 (2007) 188-196
29. Heatherton T.F., Kozlowski L.T., Frecker R.C., et al. The Fagerstrom Test for Nicotine Dependence. A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 91 (1991) 1119-1127
30. Diaz F.J., Jane M., Salto E., et al. A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry 39 3 (2005) 161-168
31. Hilsden R.J., Hodgins D., Czechowsky D., et al. Attitudes toward smoking and smoking behaviors of patients with Crohn's disease. Am J Gastroenterol 96 6 (2001) 1849-1853
32. Piper M.E., McCarthy D.E., and Baker T.B. Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res 8 3 (2006) 339-351
33. Altman D.G. Practical statistics for medical research (1991), Chapman and Hall, London
34. Hyphantis T.N., Triantafillidis J.K., Pappa S., et al. Defense mechanisms in inflammatory bowel disease. J Gastroenterol 40 (2005) 24-30
35. Kraemer H.C., Wilson G.T., Fairburn C.G., and Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 59 10 (2002) 877-883
36. Kraemer H.C., Frank E., Kupfer D.J., Moderators of treatment outcomes: clinical, research, and policy importance. JAMA;296(10):1286-1289.
37. Miles J., and Shevlin M. Moderator and mediator analysis. In: Miles J., and Shelvin M. (Eds). Applying regression and correlation (2003), Sage Publications, London 165-191
38. Fagerström K.O., Kunze M., Schoberberger R., et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control 5 1 (1996) 52-56
39. Vardavas C.I., and Kafatos A.G. Smoking policy and prevalence in Greece: an overview. Eur J Public Health 17 2 (2007) 211-213
40. Gazzard B.G., Price H.L., Libby G.W., et al. The social toll of Crohn's disease. BMJ 2 (1978) 1117-1119
41. Robertson D.A.F., Ray J., Diamond I., et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut 30 (1989) 623-626
42. Addolorato G., Capristo E., Stefannini G.F., et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity and nutritional status. Scand J Gastroenterol 32 (1997) 1013-1021
43. Heltzer J.E., Stillings W.A., Chammas S., et al. A controlled study of the association between ulcerative colitis and psychiatric illness. Dig Dis Sci 27 6 (1982) 513-518
44. Tocci A., Lepre L., Liotta G., et al. Familial and psychological risk factors of ulcerative colitis. Ital J Gastroenterol Hepatol 29 (1997) 395-398
45. Häuser W., Stallmach A., Caspary W.F., et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther 25 5 (2007) 569-578
46. Zhang S.J., Huang L.H., Wen Y.L., et al. Impact of personality and coping mechanisms on health related quality of life in liver transplantation recipients. Hepatobiliary Pancreat Dis Int 4 3 (2005) 356-359
47. Cloninger C.R., Svrakic D.M., and Przybeck T.R. A psychobiological model of temperament and character. Arch Gen Psychiatry 50 12 (1993) 975-990
48. Zuckerman M. Sensation seeking. In: Zuckerman M. (Ed). Sensation seeking and risky behavior (2007), American Psychological Association, Washington, DC 3-51
49. Vidal A., Gómez-Gil E., Sans M., et al. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis 14 7 (2008) 977-983
50. Spielberger C.D., and Jacobs G.A. Personality and smoking behavior. J Pers Assess 46 4 (1982) 396-403
51. Doran N., Spring B., McChargue D., et al. Impulsivity and smoking relapse. Nicotine Tob Res 6 4 (2004) 641-647
52. Corrigall W.A., Franklin K.B., Coen K.M., et al. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107 (1990) 285-289
53. Sziraki I., Sershen H., Benuck M., et al. Receptor systems participating in nicotine-specific effects. Neurochem Int 33 (1998) 445-457
54. Alcaro A., Huber R., and Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev. 56 2 (2007) 283-321
55. Volkow N.D., Fowler J.S., and Wang G.J. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 13 4 (1999) 337-345
56. Lipkus I.M., Barefoot J.C., Williams R.B., and Siegler I.C. Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study. Health Psychol 13 2 (1994) 149-155
57. Mitchell S.H. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl) 146 4 (1999) 455-464
58. Johnson G.J., Cosnes J., and Mansfield J.C. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther 21 8 (2005) 921-931
59. Cosnes J., Beaugerie L., Carbonnel F., et al. Decreased severity of Crohn's disease after smoking cessation. Preliminary results of a prospective intervention study. Gastroenterology 118 (2000) A870
60. Zutshi M., Hull T.L., and Hammel J. Crohn's disease: a patient's perspective. Int J Colorectal Dis 22 12 (2007) 1437-1444
61. Cosnes J., Beaugerie L., Carbonnel F., et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 120 5 (2001) 1093-1099